The year is off to a good start for Mecuris: the Munich-based medtech startup announces growth financing of €3.6 million. Investors include seed investors Bavaria Capital and the High-Tech Gründerfonds (HTGF), the international investment company Mulcan, the life science venture capital investor Vesalius Biocapital and Sana Kliniken AG, who are already at the Series A financing round participated a year ago.
Leading orthopaedic technology into the digital age — no less a goal is being pursued MecurisWith the successful completion of a growth financing round, the Munich-based startup can now continue working on making orthopedic aids such as prostheses individually manufactured for each patient using a web-based platform. Johannes Schneider-Littfeld, Chairman of the Mecuris Advisory Board, commented on the current financing round:
"Mecuris's development into a provider of digital algorithms is now clearly recognized by its partners in orthopedic patient care as a step into the future. To consistently pursue this path and based on the milestones achieved in 2019, all investors in the Series A round have decided, as planned, to continue providing the company with the necessary resources."
Expansion to include Digital Orthosis Workshop
With the fresh 3.6 million euros, Mecuris Firstly, to increase its market penetration in the European market. Secondly, the online platform 'Mecuris Solution Platform' is to be expanded to include functions in the orthotics sector. For example, the Digital Prosthesis Workshop for the creation of customized prostheses is to be supplemented by the Digital Orthosis Workshop by the end of March. This will provide the orthotist with a simple, intuitive, and time-saving option for creating orthoses completely or using partial steps in a web-based workflow.
